HOLLISTON, Mass., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the third quarter ended September 30, 2011 before market trading hours on Thursday, November 3, 2011.
